Your browser doesn't support javascript.
loading
Prognostic gene expression signature for high-grade serous ovarian cancer.
Millstein, J; Budden, T; Goode, E L; Anglesio, M S; Talhouk, A; Intermaggio, M P; Leong, H S; Chen, S; Elatre, W; Gilks, B; Nazeran, T; Volchek, M; Bentley, R C; Wang, C; Chiu, D S; Kommoss, S; Leung, S C Y; Senz, J; Lum, A; Chow, V; Sudderuddin, H; Mackenzie, R; George, J; Fereday, S; Hendley, J; Traficante, N; Steed, H; Koziak, J M; Köbel, M; McNeish, I A; Goranova, T; Ennis, D; Macintyre, G; Silva De Silva, D; Ramón Y Cajal, T; García-Donas, J; Hernando Polo, S; Rodriguez, G C; Cushing-Haugen, K L; Harris, H R; Greene, C S; Zelaya, R A; Behrens, S; Fortner, R T; Sinn, P; Herpel, E; Lester, J; Lubinski, J; Oszurek, O; Toloczko, A.
Afiliación
  • Millstein J; Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Budden T; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, Australia; CRUK Manchester Institute, The University of Manchester, Manchester, UK.
  • Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, USA.
  • Anglesio MS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, Univ
  • Talhouk A; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada.
  • Intermaggio MP; School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, Australia.
  • Leong HS; Peter MacCallum Cancer Center, Melbourne, Australia.
  • Chen S; Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Elatre W; Department of Pathology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, USA.
  • Gilks B; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Nazeran T; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Volchek M; Anatomical Pathology, Royal Women's Hospital, Parkville, Australia.
  • Bentley RC; Department of Pathology, Duke University Hospital, Durham, USA.
  • Wang C; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, USA.
  • Chiu DS; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Leung SCY; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Senz J; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Lum A; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Chow V; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Sudderuddin H; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • Mackenzie R; British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, Canada.
  • George J; The Jackson Laboratory for Genomic Medicine, Farmington, USA.
  • Fereday S; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
  • Hendley J; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
  • Traficante N; Peter MacCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
  • Steed H; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Royal Alexandra Hospital, Edmonton, Canada.
  • Koziak JM; Alberta Health Services-Cancer Care, Calgary, Canada.
  • Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, Canada.
  • McNeish IA; Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Ennis D; Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, Imperial College London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Silva De Silva D; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Ramón Y Cajal T; Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain.
  • García-Donas J; HM Hospitales D Centro Integral Oncológico HM Clara Campal, Madrid, Spain.
  • Hernando Polo S; Medical Oncology Service, Hospital Universitario Funcacion Alcorcon, Alcorcón, Spain.
  • Rodriguez GC; Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, USA.
  • Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA; Department of Epidemiology, University of Washington, Seattle, USA.
  • Greene CS; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
  • Zelaya RA; Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, USA.
  • Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sinn P; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Herpel E; Department of Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
  • Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, USA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Oszurek O; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Toloczko A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Ann Oncol ; 31(9): 1240-1250, 2020 09.
Article en En | MEDLINE | ID: mdl-32473302
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido